Alfa Wassermann S.p.a.

Alfasigma S.p.a.

Vittoria Lauro

Giuseppe Claudio Viscomi

Paola Maffei

Dario Braga

Donatella Confortini

Maria Barbanti

Miriam Barbanti

Fiorella Calanni

Beatrice Vitali

Federica Cruciani

Marco Mascagni

Mascia Federici

The invention relates generally to pharmaceutical compositions comprising rifaximin effective at treating vaginal infections, and in particular bacterial vaginosis. The pharmaceutical compositions comprising rifaximin granules are characterized in that they release rifaximin in the vagina in a controlled way. The present invention also relates to processes for preparation of the rifaximin pharmaceutical compositions and their use in the treatment of vaginal infections. Effective dosages and courses of treatment useful and effective at recovering from the disease and preventing any possible relapse are also provided.

Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections

The present invention describes rifaximin powder and to a process for preparing the same. The invention relates also to a pharmaceutical composition in solid form comprising said rifaximin, pharmaceutically acceptable excipients and optionally other ingredients. The compositions according to the invention are suitable for oral administration and are characterized by producing a controlled release of rifaximin, whereby a long-lasting effect is obtained in a patient.

Rifaximin powder, process for preparing the same an controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect

Rifaximin powder, process for preparing the same and controlled release compositions containing said rifaximin useful for obtaining a long-lasting effect

Growing community of inventors

Bologna, Italy

Vittoria Lauro